Solasia Pharma K.K. to Start China Clinical Trial of Anti-Nausea Patch Product

Published: Feb 05, 2013

by Richard Daverman, PhD

February 5, 2013 -- Solasia, a Japan-headquartered company, has received a Clinical Trial Permit from the SFDA for China trials of Sancuso®, the company’s transdermal patch product for the treatment of chemotherapy-induced nausea and vomiting. Solasia in-licensed rights to Sancuso® for Southeast Asia in 2008 from a British pharma, ProStrakan. Solasia will begin a trial of the product immediately and expects to file a New Drug Application in China during Q4 of 2013. More details....

Back to news